| References |
- Bauernfeind A, Stemplinger I, Jungwirth R, Giamarellou H. Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance. Antimicrob Agents Chemother. 1996 Jan;40(1):221-4.PubMedPMID:8787910
|
- Decré D, Verdet C, Raskine L, Blanchard H, Burghoffer B, Philippon A, Sanson-Le-Pors MJ, Petit JC, Arlet G. Characterization of CMY-typebeta-lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area. J Antimicrob Chemother. 2002 Nov;50(5):681-8.PubMedPMID: 12407124
|
- Colinon C, Miriagou V, Carattoli A, Luzzaro F, Rossolini GM. Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases. J Antimicrob Chemother. 2007 Aug;60(2):258-62. Epub 2007 May 31.PubMed PMID:17540674
|
- Call DR, Singer RS, Meng D, Broschat SL, Orfe LH, Anderson JM, Herndon DR,Kappmeyer LS, Daniels JB, Besser TE. blaCMY-2-positive IncA/C plasmids from Escherichia coli and Salmonella enterica are a distinct component of a larger lineage of plasmids. Antimicrob Agents Chemother. 2010 Feb;54(2):590-6. doi:10.1128/AAC.00055-09. Epub 2009 Nov 30.PubMedPMID: 19949054
|
- Literacka E, Empel J, Baraniak A, Sadowy E, Hryniewicz W, Gniadkowski M. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob Agents Chemother. 2004 Nov;48(11):4136-43.PubMedPMID: 15504832
|
- Harada S, Ishii Y, Saga T, Tateda K, Yamaguchi K. Chromosomally encoded blaCMY-2 located on a novel SXT/R391-related integrating conjugative element in a Proteus mirabilis clinical isolate. Antimicrob Agents Chemother. 2010 Sep;54(9):3545-50. doi: 10.1128/AAC.00111-10. Epub 2010 Jun 21.PubMedPMID:20566768
|
- D'Andrea MM, Nucleo E, Luzzaro F, Giani T, Migliavacca R, Vailati F, Kroumova V, Pagani L, Rossolini GM. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob Agents Chemother. 2006 Feb;50(2):618-24.PubMedPMID: 16436718
|
- Stapleton PD, Shannon KP, French GL. Carbapenem resistance in Escherichia coli associated with plasmid-determined CMY-4 beta-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother. 1999 May;43(5):1206-10.PubMedPMID: 10223937
|
- Lee SH, Kim JY, Lee GS, Cheon SH, An YJ, Jeong SH, Lee KJ. Characterization of bla CMY-11, an AmpC-type plasmid-mediated beta-lactamase gene in a Korean clinicalisolate of Escherichia coli. J Antimicrob Chemother. 2002 Feb;49(2):269-73.PubMedPMID: 11815567
|
- Lee SH, Jeong SH, Park YM. Characterization of blaCMY-10 a novel,plasmid-encoded AmpC-type beta-lactamase gene in a clinical isolate of Enterobacter aerogenes. J Appl Microbiol. 2003;95(4):744-52.PubMedPMID:12969288
|
- Zioga A, Whichard JM, Kotsakis SD, Tzouvelekis LS, Tzelepi E, Miriagou V.CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids. AntimicrobAgents Chemother. 2009 Mar;53(3):1256-9. doi: 10.1128/AAC.01284-08. Epub 2008 Dec22.PubMedPMID: 19104021
|
- Pan J, Hu L, Yu F, Chen C, Zhang X. Coexistence of multipleantimicrobial-resistance genes in a carbapenem-resistant Citrobacter freundiiclinical isolate from China. J Med Microbiol. 2010 May;59(Pt 5):622-3. doi:10.1099/jmm.0.016287-0. Epub 2010 Jan 28.PubMedPMID: 20110384
|
- Wu SW, Dornbusch K, Kronvall G, Norgren M. Characterization and nucleotidesequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-typebeta-lactamase: confirmation that the plasmid-mediated cephamycinase originatedfrom the Citrobacter freundii AmpC beta-lactamase. Antimicrob Agents Chemother.1999 Jun;43(6):1350-7.PubMedPMID: 10348751
|
- Endimiani A, Doi Y, Bethel CR, Taracila M, Adams-Haduch JM, O'Keefe A, HujerAM, Paterson DL, Skalweit MJ, Page MG, Drawz SM, Bonomo RA. Enhancing resistance tocephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.Biochemistry.2010 Feb 9;49(5):1014-23. doi: 10.1021/bi9015549.PubMedPMID:19938877
|
- Doi Y, Paterson DL, Adams-Haduch JM, Sidjabat HE, O'Keefe A, Endimiani A,Bonomo RA. Reduced susceptibility to cefepime among Escherichia coli clinicalisolates producing novel variants of CMY-2 beta-lactamase. Antimicrob AgentsChemother. 2009 Jul;53(7):3159-61. doi: 10.1128/AAC.00133-09. Epub 2009 May 4PubMedPMID: 19414578
|
| Bret L, Chanal-Claris C, Sirot D, Chaibi EB, Labia R, Sirot J. Chromosomally
encoded ampC-type beta-lactamase in a clinical isolate of Proteus mirabilis.
Antimicrob Agents Chemother. 1998 May;42(5):1110-4. PubMedPMID:9593136
|
|
Verdet C, Arlet G, Ben Redjeb S, Ben Hassen A, Lagrange PH, Philippon A.
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a
Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett. 1998 Dec
15;169(2):235-40.PubMedPMID: 9868767
|
|
Wu SW, Dornbusch K, Kronvall G, Norgren M. Characterization and nucleotide
sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type
beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated
from the Citrobacter freundii AmpC beta-lactamase. Antimicrob Agents Chemother.
1999 Jun;43(6):1350-7.PubMedPMID:10348751
|
|
Hanson ND, Moland ES, Hossain A, Neville SA, Gosbell IB, Thomson KS. Unusual
Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and
OXA-30 beta-lactamases. J Antimicrob Chemother. 2002 Jun;49(6):1011-4.PubMedPMID: 12039894
|
|
Yan JJ, Wu SM, Tsai SH, Wu JJ, Su IJ. Prevalence of SHV-12 among clinical
isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and
identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob
Agents Chemother. 2000 Jun;44(6):1438-42.PubMed PMID:10817689
|
|
Verdet C, Arlet G, Ben Redjeb S, Ben Hassen A, Lagrange PH, Philippon A.
Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a
Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett. 1998 Dec
15;169(2):235-40.PubMedPMID: 9868767
|
|
Decré D, Verdet C, Raskine L, Blanchard H, Burghoffer B, Philippon A,
Sanson-Le-Pors MJ, Petit JC, Arlet G. Characterization of CMY-type
beta-lactamases in clinical strains of Proteus mirabilis and Klebsiella
pneumoniae isolated in four hospitals in the Paris area. J Antimicrob Chemother.
2002 Nov;50(5):681-8.PubMed PMID:12407124
|
|
Miriagou V, Tzouvelekis LS, Villa L, Lebessi E, Vatopoulos AC, Carattoli A,
Tzelepi E. CMY-13, a novel inducible cephalosporinase encoded by an Escherichia
coli plasmid. Antimicrob Agents Chemother. 2004 Aug;48(8):3172-4.PubMedPMID: PMC478546
|
|
Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, Yong D, Chong Y. Prevalence
of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella
pneumoniae in Korea. Microb Drug Resist. 2006 Spring;12(1):44-9.PubMed PMID:16584308
|
|
Wachino J, Kurokawa H, Suzuki S, Yamane K, Shibata N, Kimura K, Ike Y, Arakawa
Y. Horizontal transfer of blaCMY-bearing plasmids among clinical Escherichia coli
and Klebsiella pneumoniae isolates and emergence of cefepime-hydrolyzing CMY-19PubMedPMID: 16436707
|
|
Mocktar C, Govinden U, Sturm AW, Essack SY. CMY-20, a novel AmpC-type
beta-lactamase from South African clinical Escherichia coli isolates.PubMed PMID:18207348
|
|
Hopkins KL, Deheer-Graham A, Karisik E, Batchelor MJ, Liebana E, Threlfall EJ.
New plasmid-mediated AmpC beta-lactamase (CMY-21) in Escherichia coli isolated in
the UK. Int J Antimicrob Agents. 2006 Jul;28(1):80-2. Epub 2006 May 23.PubMedPMID: 16716570
|
|
Mata C, Miró E, Rivera A, Mirelis B, Coll P, Navarro F. Prevalence of acquired
AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC
genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect.PubMed PMID:19523051
|
|
Ahmed AM, Motoi Y, Sato M, Maruyama A, Watanabe H, Fukumoto Y, Shimamoto T.
Zoo animals as reservoirs of gram-negative bacteria harboring integrons and
antimicrobial resistance genes.PubMedPMID: 17720829
|
|
Adler H, Fenner L, Walter P, Hohler D, Schultheiss E, Oezcan S, Frei R.
Plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking inducible
chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence
of the different molecular types in Switzerland.PubMed PMID:18065410
|
|
Empel J, Baraniak A, Literacka E, Mrówka A, Fiett J, Sadowy E, Hryniewicz W,
Gniadkowski M; Beta-PL Study Group. Molecular survey of beta-lactamases
conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from
Polish hospitals. Antimicrob Agents Chemother.PubMed PMID: 18458126
|
|
Hammad AM, Ishida Y, Shimamoto T. Prevalence and molecular characterization of
ampicillin-resistant Enterobacteriaceae isolated from traditional Egyptian
Domiati cheese.PubMed PMID:19343954
|
|
Hentschke M, Kotsakis SD, Wolters M, Heisig P, Miriagou V, Aepfelbacher M.
CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase.PubMed PMID: 21388298
|
|
D'Andrea MM, Literacka E, Zioga A, Giani T, Baraniak A, Fiett J, Sadowy E,
Tassios PT, Rossolini GM, Gniadkowski M, Miriagou V. Evolution and spread of a
multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type
cephalosporinases in Europe. Antimicrob Agents Chemother. 2011 Jun;55(6):2735-42.
doi: 10.1128/AAC.01736-10. Epub 2011 Mar 14.PubMed PMID:21402851
|
|
Miró E, Agüero J, Larrosa MN, Fernández A, Conejo MC, Bou G, González-López
JJ, Lara N, Martínez-Martínez L, Oliver A, Aracil B, Oteo J, Pascual A,
Rodríguez-Baño J, Zamorano L, Navarro F. Prevalence and molecular epidemiology of
acquired AmpC ?-lactamases and carbapenemases in Enterobacteriaceae isolates from
35 hospitals in Spain. Eur J Clin Microbiol Infect Dis. 2013 Feb;32(2):253-9.
doi: 10.1007/s10096-012-1737-0. Epub 2012 Sep 7. Erratum in: Eur J Clin Microbiol
Infect Dis. 2013 Feb;32(2):261-2. PubMed PMID: 22956023
|
|
Schneider I, Markovska R, Marteva-Proevska Y, Mitov I, Markova B, Bauernfeind
A. Detection of CMY-99, a novel acquired AmpC-Type ?-lactamase, and VIM-1 in
Proteus mirabilis isolates in Bulgaria. Antimicrob Agents Chemother.
2014;58(1):620-1. doi: 10.1128/AAC.01450-13. Epub 2013 Oct 28.PubMed PMID:24165184
|
|
Bortolaia V, Hansen KH, Nielsen CA, Fritsche TR, Guardabassi L. High diversity
of plasmids harbouring blaCMY-2 among clinical Escherichia coli isolates from
humans and companion animals in the upper Midwestern USA. J Antimicrob Chemother.
2014 Jun;69(6):1492-6. doi: 10.1093/jac/dku011. Epub 2014 Feb 4.PubMed PMID: 24500191
|
|
Okubo T, Sato T, Yokota S, Usui M, Tamura Y. Comparison of broad-spectrum
cephalosporin-resistant Escherichia coli isolated from dogs and humans in
Hokkaido, Japan. J Infect Chemother. 2014 Apr;20(4):243-9. doi:
10.1016/j.jiac.2013.12.003. Epub 2014 Jan 24. PubMed PMID: 24709044
|
